Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide for Hepatic Encephalopathy Recurrence Prevention
NCT04161053Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Nov 2018
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in hepatic encephalopathy (HE), sponsored by Tanta University. Started Nov 2018; status: recruiting.
02
Drugs
nitazoxanide
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT04161053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04161053.